You are here

Home › Listings › Life Sciences › Rize Oncology Inc.

Rize Oncology Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
RIZE
CSE Index: 
Currency: 

Rize Oncology Inc. is a pharmaceutical company dedicated to developing innovative oncology therapies. With a focus on advancing treatments for soft tissue sarcoma, Rize Oncology aims to make a meaningful impact on patients' lives by Turning the Tide on Metastasis.

You are here

Home

Rize Oncology Inc. (RIZE)

SEDAR Information

Search form

Company Info

Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
Canada
Phone
(514) 796-2640
Email
[email protected]
Website
https://www.rizeoncology.com
Listing date
Monday, March 28, 2022
Transfer Agent
Odyssey Trust Company

Capitalization

Issued & Outstanding: 
75744674
Reserved for Issuance: 
17942855

Company Officers

Roland Boivin, Chief Executive Officer
Daren Graham, Chairman
James O'Neill, Chief Financial Officer
John Rothman, Chief Scientific Officer

News Releases

09/01/2025

GeneTether Therapeutics Announces Name Change to Rize Oncology, Reflecting New Focus on Oncology

06/01/2025

GeneTether Announces Closing of Licensing Agreement for STS-201 and $500,000 Non-Brokered Private Placement

Bulletins

10/01/2025

2025-0106– Name and Symbol Change - GeneTether Therapeutics Inc. (GTTX)

le 10 janvier/January 2025

GeneTether Therapeutics Inc. (GTTX) has announced a name and symbol change to Rize Oncology Inc. (RIZE)

Shares will begin trading under the new name and symbol and with a new CUSIP number on January 13, 2025.

Disclosure documents are available at www.thecse.com.

CSE Filings

CDS Confirmation Letter

Certificate of Name Change

Specimen Share Certificate

Letter from Odyssey Trust Company regarding Name Change

Letter from Odyssey Trust Company